Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Filing Date
Apr 14, 2021
Document Date
May 26, 2021
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.